Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EDOXABAN Cause C-reactive protein increased? 20 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of C-reactive protein increased have been filed in association with EDOXABAN (SAVAYSA). This represents 0.2% of all adverse event reports for EDOXABAN.

20
Reports of C-reactive protein increased with EDOXABAN
0.2%
of all EDOXABAN reports
1
Deaths
18
Hospitalizations

How Dangerous Is C-reactive protein increased From EDOXABAN?

Of the 20 reports, 1 (5.0%) resulted in death, 18 (90.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does EDOXABAN Cause?

Anaemia (663) Cerebral infarction (419) Gastrointestinal haemorrhage (378) Renal impairment (359) Cerebrovascular accident (337) Dyspnoea (331) General physical health deterioration (315) Haematuria (312) Fall (298) Cardiac failure (272)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which EDOXABAN Alternatives Have Lower C-reactive protein increased Risk?

EDOXABAN vs EDOXABAN TOSILATE EDOXABAN vs EFALIZUMAB EDOXABAN vs EFANESOCTOCOG ALFA EDOXABAN vs EFAVIRENZ EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL

Related Pages

EDOXABAN Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased EDOXABAN Demographics